(NYSE: CVS) Cvs Health's forecast annual revenue growth rate of 4.49% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 5.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Cvs Health's revenue in 2024 is $360,935,000,000.On average, 9 Wall Street analysts forecast CVS's revenue for 2024 to be $463,305,911,575,986, with the lowest CVS revenue forecast at $459,295,854,860,932, and the highest CVS revenue forecast at $466,470,233,562,788. On average, 9 Wall Street analysts forecast CVS's revenue for 2025 to be $486,812,051,147,973, with the lowest CVS revenue forecast at $465,075,137,579,004, and the highest CVS revenue forecast at $512,217,292,589,170.
In 2026, CVS is forecast to generate $518,915,763,163,459 in revenue, with the lowest revenue forecast at $497,546,865,947,351 and the highest revenue forecast at $567,067,546,864,864.